Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/7475
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYenny Triamyanti, Vincentina-
dc.contributor.authorHerawati, Fauna-
dc.contributor.authorYulia, Rika-
dc.contributor.authorKadir Jaelani, Abdul-
dc.date.accessioned2024-11-07T04:22:58Z-
dc.date.available2024-11-07T04:22:58Z-
dc.date.issued2022-08-31-
dc.identifier.issn25808303-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/7475-
dc.description.abstractAbstract Background: Coronavirus Disease 2019 (Covid-19) is an infectious disease. Common signs and symptoms of Covid-19 infection include acute respiratory distress such as fever, cough and shortness of breath. Analysis of drug use in Non-Ventilator Covid-19 patients needs to be carried out to provide an overview of drug therapy currently being used based on the Covid-19 Management Guidelines Edition 3rd because so far, there has not been a single type of drug that has received marketing authorization for Covid-19 therapy. Objectives: This study aims to determine patient profiles, therapeutic outcomes, suitability of drug use with Covid-19 Management Guidelines 3 rd edition, the quantity of antibiotic use using the DDD/100 patient-days method and antivirals. Methods: The method used in this study is an observational design study which was analyzed descriptively with retrospective data collection. Result: Based on the profile of drug use in COVID-19 patients, there are 31 types of drug classes. The most consumed drugs were antibacterial (91%) and analgesics (91%), followed by vitamins (89%) and supplements (85%). Based on the DDD/100 patient-days value, the most widely used antibiotics were Azithromycin. Conclusion: The patient's profile at the time of admission to the hospital was 44% moderate and 56% severe. The condition of patients at the time of discharge from the hospital with a moderate degree using antivirals and antibiotics were more recovered and returned home with improvements with percentages of 84.1% and 88.64%, respectively. Keywords: covid-19, non-ventilator patients, antibiotic, antiviralen_US
dc.publisherFaculty of Pharmacy Univesrsitas Airlanggaen_US
dc.subjectcovid-19,en_US
dc.subjectnon-ventilator patients,en_US
dc.subjectantibiotic,en_US
dc.subjectantiviralen_US
dc.titleAnalysis of Drug Use in Non-Ventilator Covid-19 Patients at Bangil Hospitalen_US
dc.typeArticleen_US
Appears in Collections:VOL 9 NO 2 2022

Files in This Item:
File Description SizeFormat 
168-176.pdf466.75 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.